Boardroom Briefing

Major IPO for Malin

22nd March, 2015

✽ Biotech firm Malin has raised up to €330 million in one of Europe’s biggest life science IPOs.

The Irish company, which was set up by a number of former Elan executives, beat its target range of €275 to €325 million. The company will be admitted to Ireland’s ESM (Enterprise Securities Market) on Wednesday.

Dr Adrian Howd, Malin’s chief executive, said the company was “very gratified at the level of investor support...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Tom Maguire: Tax changes we make now could help business for years

More Business Tom Maguire 9 months ago

The Daily Briefing

The Daily Briefing